10 May 2018 - The European Federation of Pharmaceutical Industries and Associations (EFPIA) has welcomed the European Commission’s proposal for a Regulation on health technology assessment.
The proposal builds on many years of voluntary cooperation in HTA between member states at European Union level.
It presents a unique opportunity for greater alignment in Europe on clinical evidence generation requirements, ensuring consistency, transparency and synergies in clinical assessments by member states and evidence that is relevant for Europe.